← Back to Search

Naps for Infant Memory Development

Research Sponsored by University of Massachusetts, Amherst
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infants must be 9 months at the time of enrollment
Infants must have normal birthweight (5.5 to 10 lbs) and gestational length (36-41 weeks)
Must not have
Infants with visual or motor disability
Infants born premature (<36 weeks gestational age)
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights


"This trial aims to study how naps affect memory development in infants aged 9 to 15 months. Memory is tested by observing if the child imitates a toy after seeing an experimenter interact

Who is the study for?
This trial is for infants aged 9 to 15 months to explore how napping affects their memory. Infants must be healthy with no sleep disorders like narcolepsy. They'll wear a motion-detecting watch and have electrodes on their head during naps at the study visits, which happen every three months.Check my eligibility
What is being tested?
The study tests if there's a change in how babies remember things before and after they nap. Researchers will see if the way infants imitate actions with toys changes over time, from ages 9 to 15 months, by observing them before and after morning or afternoon naps.See study design
What are the potential side effects?
There are minimal side effects expected in this study as it involves routine activities like wearing a watch and taking naps. However, some discomfort may occur from wearing the electrodes during sleep.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
My child is 9 months old.
My baby was born with a normal weight and at full term.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
My infant has a visual or motor disability.
My baby was born before 36 weeks of pregnancy.
My infant has traveled across time zones within the last 2 weeks.
My infant has a fever or symptoms of a respiratory illness.
My infant has a physical handicap that affects vision or hearing.
My infant has had a neurological injury like seizures, brain tumor, or stroke.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Memory accuracy

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wake (non-nap)Experimental Treatment1 Intervention
Wake is promoted
Group II: NapExperimental Treatment1 Intervention
Naps are promoted
First Studied
Drug Approval Stage
How many patients have taken this drug

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkOTHER
157 Previous Clinical Trials
46,152 Total Patients Enrolled
University of Massachusetts, AmherstLead Sponsor
80 Previous Clinical Trials
468,052 Total Patients Enrolled
~67 spots leftby Jan 2028